NH
NantHealth Inc
Price:  
1.35 
USD
Volume:  
232,491.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NH EV/EBITDA

-6047.0%
Upside

As of 2026-11-08, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.3x - 10.8x 6.6x
Forward P/E multiples 6.7x - 14.2x 9.0x
Fair Price (75.33) - (95.34) (80.28)
Upside -5680.1% - -7162.2% -6047.0%
1.35 USD
Stock Price
(80.28) USD
Fair Price

NH EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA